Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Aeglea BioTherapeutics Q3 Earnings

Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aeglea BioTherapeutics beat estimated earnings by 17.39%, reporting an EPS of $-0.19 versus an estimate of $-0.23.

Revenue was down $1.23 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 1.23% increase in the share price the next day.

 

To track all earnings releases for Aeglea BioTherapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

PotlatchDeltic Earnings Preview

By Benzinga Insights
Today, 5:14 PM
PotlatchDeltic (NASDAQ:PCH) is set to give its latest quarterly earnings report on Monday, 2022-04-25. Here's what investors need to know before the announcement. Analysts estimate that PotlatchDeltic will report an earnings per share (EPS) of $2.14.

PCH